Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > iCAD CEO Ken Ferry to Speak at the 2007 Future in Review Conference

Abstract:
iCAD, Inc. (Nasdaq:iCAD), an industry-leading provider of Computer-Aided Detection (CAD)
solutions for the early identification of cancer, today announced that the
Company's CEO, Ken Ferry, has been invited to participate in the
prestigious Future in Review (FiRe) Conference. The Conference runs from
May 22 to 25, 2007, at the Hotel del Coronado in San Diego, California.
iCAD joins EMC, Symantec and Intel Health Research & Innovation Group,
among other technology leaders at the conference.

iCAD CEO Ken Ferry to Speak at the 2007 Future in Review Conference

NASHUA, NH | Posted on May 22nd, 2007

Mark Anderson, founder and publisher of the Strategic News Service and
expert source on future technologies, contributes to Fortune, the Wall
Street Journal and the New York Times correctly predicting accurate
forecasts of important technology market shifts. The FiRe conference hosted
by Mark Anderson provides world experts and participants with a view of the
future in technology, including nanotechnology, space travel, biology and
medical diagnostics, policy, and other fields.

"The annual FiRe conference offers participants exposure to new ideas
and thought leaders on the cutting edge of technology," said Mark Anderson,
chairman of FiRe and founder and publisher of the Strategic News Service.
"iCAD was selected to participate in FiRe because the Company's CAD
technology is shaping the future of cancer screening, from mammography to
virtual colonoscopy and beyond. CAD technology is vital to the early
identification of cancer, which studies have shown impacts treatment
options, survival and overall patient outcomes."

"iCAD is honored to be selected as a participant at the 2007 FiRe
conference," said Ken Ferry, Chief Executive Officer of iCAD. "As the only
company 100 percent focused on advancing CAD solutions, iCAD is leading the
development of future systems that enable physicians to detect cancers
earlier. The Company's commitment to digital imaging will continue to
expand as we explore applications in 3D mammography and virtual
colonoscopy."

####

About iCAD, Inc.
iCAD, Inc. (Nasdaq: iCAD) is an industry-leading provider of Computer-
Aided Detection (CAD) solutions that enable healthcare professionals to
better serve patients by identifying pathologies and pinpointing cancer
earlier. iCAD offers a comprehensive range of high-performance, upgradeable
CAD systems for the high, mid and low volume mammography markets. iCAD is
entrusted with the task of early cancer detection by over one thousand
women's healthcare centers worldwide. For more information, call
+1-877-iCADnow or visit http://www.icadmed.com .

For more information, please click here

Contacts:
Investor Relations,
Kevin McGrath
Cameron Associates
212-245-4577


iCAD Public Relations
Wendy Ryan
Schwartz Communications
781-684-0770

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Events/Classes

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE